Method of treatment using substituted imidazo[1,2b]pyridazine compounds
US9796723B2 · kind B2 · utility
15Cited by
35References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2017 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Jan 9, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula Iin which R1, R2, R3, R4, X, Y and n have the meanings given in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.